Cargando…

A Delphi Consensus Approach for Difficult-to-Treat Patients with Severe Hemophilia A without Inhibitors

INTRODUCTION: Over the past decade, there has been an increase in novel therapeutic options to treat hemophilia A. It is still unclear how these novel treatments are used in the management of patients with hemophilia A, particularly those with challenging clinical scenarios who are typically exclude...

Descripción completa

Detalles Bibliográficos
Autores principales:	Veeranki, Sreenivas P, Pednekar, Priti, Graf, Marlon, Tuly, Rifat, Recht, Michael, Batt, Katharine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8544791/ https://www.ncbi.nlm.nih.gov/pubmed/34707422 http://dx.doi.org/10.2147/JBM.S334852

Ejemplares similares

Understanding the evolution of coverage policies for prophylaxis treatments of hemophilia A without inhibitors: a payer Delphi panel
por: Graf, Marlon, et al.
Publicado: (2021)

Current Choices and Management of Treatment in Persons with Severe Hemophilia A without Inhibitors: A Mini-Delphi Consensus
por: Coppola, Antonio, et al.
Publicado: (2022)

Construct validity of patient-reported outcome instruments in US adults with hemophilia: results from the Pain, Functional Impairment, and Quality of life (P-FiQ) study
por: Batt, Katharine, et al.
Publicado: (2017)

Value of a cure for sickle cell disease in reducing economic disparities
por: Graf, Marlon, et al.
Publicado: (2022)

Hemophilia without prophylaxis: Assessment of joint range of motion and factor activity
por: Wang, Michael, et al.
Publicado: (2020)

Reliability of patient-reported outcome instruments in US adults with hemophilia: the Pain, Functional Impairment and Quality of life (P-FiQ) study
por: Kempton, Christine L, et al.
Publicado: (2017)

Classification and Treatment of Angioedema without Wheals: A Spanish Delphi Consensus
por: Caballero, Teresa, et al.
Publicado: (2022)

Schizophrenia population health management: perspectives of and lessons learned from population health decision makers
por: Roach, Meaghan, et al.
Publicado: (2021)

Consensus recommendations for the diagnosis and treatment of acquired hemophilia A
por: Collins, Peter, et al.
Publicado: (2010)

Expert consensus on difficult airway assessment
por: Xia, Ming, et al.
Publicado: (2023)

Treating subclinical hypothyroidism in individuals with or without mental health problems –A Delphi based expert consensus study in two countries
por: Lieber, Ingrid, et al.
Publicado: (2023)

Internal consistency and item-total correlation of patient-reported outcome instruments and hemophilia joint health score v2.1 in US adult people with hemophilia: results from the Pain, Functional Impairment, and Quality of life (P-FiQ) study
por: Wang, Michael, et al.
Publicado: (2017)

Physical activity and bleeding outcomes among people with severe hemophilia on extended half‐life or conventional recombinant factors
por: Shrestha, Anshu, et al.
Publicado: (2020)

Trends and Determinants of Up-to-date Status with Colorectal Cancer Screening in Tennessee, 2002-2008
por: Veeranki, Sreenivas P, et al.
Publicado: (2014)

Indirect Treatment Comparison of Damoctocog Alfa Pegol versus Turoctocog Alfa Pegol as Prophylactic Treatment in Patients with Hemophilia A
por: Vashi, Parth, et al.
Publicado: (2021)

Examining consensus for a standardised patient assessment in community paramedicine home visits: a RAND/UCLA-modified Delphi Study
por: Leyenaar, Matthew S, et al.
Publicado: (2019)

Adenomyosis: Difficult to Diagnose, and Difficult to Treat
por: Wood, C.
Publicado: (2001)

Difficult-to-treat asthma, is it really difficult?
por: Al-Hajjaj, Mohamed S.
Publicado: (2011)

Mixing and administration times of bypassing agents: observations from the Dosing Observational Study in Hemophilia (DOSE)
por: Maahs, Jennifer, et al.
Publicado: (2014)

Consensus on Hearing Aid Candidature and Fitting for Mild Hearing Loss, With and Without Tinnitus: Delphi Review
por: Sereda, Magdalena, et al.
Publicado: (2015)

Controversies in the treatment of advanced ovarian cancer in the PARP inhibitors era: a Delphi consensus
por: Redondo, Andrés, et al.
Publicado: (2023)

Consensus Review of the Treatment of Cardiovascular Disease in People With Hemophilia A and B
por: Ferraris, Victor A., et al.
Publicado: (2015)

A Retrospective Analysis of the American Thrombosis and Hemostasis Network Dataset Describing Outcomes of Dental Extractions in Persons with Hemophilia
por: Messenger, Heather, et al.
Publicado: (2023)

A Successful Coronary Artery Bypass Operation with Intermittent Factor VIII Administration in a Hemophilia A Patient Who Was Admitted Due to Acute Myocardial Infarction: A Rare and Difficult Case
por: Topaloğlu, Ulaş Serkan, et al.
Publicado: (2019)

Consensus Definition of Misophonia: A Delphi Study
por: Swedo, Susan E., et al.
Publicado: (2022)

Developing consensus in Histopathology: the role of the Delphi method
por: Taze, Dilek, et al.
Publicado: (2022)

A Delphi consensus statement for digital surgery
por: Lam, Kyle, et al.
Publicado: (2022)

Measuring multimorbidity in research: Delphi consensus study
por: Ho, Iris S S, et al.
Publicado: (2022)

Evaluation of transfusion-related complications along with estimation of inhibitors in patients with hemophilia: A pilot study from a single center
por: Dubey, Anju, et al.
Publicado: (2013)

Focusing in on use of pharmacokinetic profiles in routine hemophilia care
por: Croteau, Stacy E., et al.
Publicado: (2018)

Evaluation of clinical characteristics, health care resource utilization, and cost outcomes of hemophilia A carriers and noncarriers in the United States: A real-world comparative analysis
por: Xing, Shan, et al.
Publicado: (2023)

Quality of Life in Hemophilia Complicated by Inhibitors
por: Bastani, P, et al.
Publicado: (2012)

Escape or Fight: Inhibitors in Hemophilia A
por: Merlin, Simone, et al.
Publicado: (2020)

Molecular Mechanisms of Inhibitor Development in Hemophilia
por: Tieu, Paul, et al.
Publicado: (2020)

Verification and Comparison of Chromogenic Factor VIII Activity Assays in Patients With Hemophilia Treated With and Without Emicizumab
por: Lee, Min Young, et al.
Publicado: (2023)

Resource utilization and treatment costs of patients with severe hemophilia A: Real‐world data from the ATHNdataset
por: Recht, Michael, et al.
Publicado: (2022)

Difficult and complicated oral ulceration: an expert consensus guideline for diagnosis
por: Zeng, Xin, et al.
Publicado: (2022)

The prevalence and risk factors of inhibitor development of FVIII in previously treated patients with hemophilia A
por: Kim, Ju Young, et al.
Publicado: (2019)

Factor VIII inhibitors in hemophilia A treated with emicizumab: longitudinal follow-up of outcomes
por: Levy-Mendelovich, Sarina, et al.
Publicado: (2023)

Safe and Successful Surgical Outcome in Persons with Hemophilia A with and without Inhibitors Treated with Emicizumab: A Large, Single Center, Real-World Experience
por: Castaman, Giancarlo, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ppmnqnkb17h2cglks1rrmqh3es